Lanean...
Dapagliflozin for the treatment of type 2 diabetes: a review of the literature
OBJECTIVE: Dapagliflozin was the first drug in a class of therapies that took a new approach to glycemic control in adults with type 2 diabetes (T2D). It is an inhibitor of the sodium glucose cotransporter, resident in the proximal nephron, which is responsible for the recovery of filtered glucose b...
Gorde:
| Argitaratua izan da: | Drug Des Devel Ther |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4267514/ https://ncbi.nlm.nih.gov/pubmed/25525338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S50963 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|